Diabetes-Focused Biotech Prices $40M IPO Well Below Range
Venture-backed biopharmaceutical company Applied Therapeutics Inc. began trading on the Nasdaq Global Market on Tuesday, raising $40 million in its Cooley LLP-led initial public offering after pricing shares significantly below its...To view the full article, register now.
Already a subscriber? Click here to view full article